Caxton Associates LP Merck & Co., Inc. Transaction History

Caxton Associates LP

$2.65 Billion
Q3 2024

A detailed history of Caxton Associates LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Caxton Associates LP holds 16,890 shares of MRK stock, worth $1.66 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

16,890

Previous 23,141 27.01%

Holding current value

$1.66 Million

Previous $2.86 Million 33.03%

% of portfolio

0.07%

Previous 0.1%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$111.15 - $128.97 $694,798 - $806,191	-6,251 Reduced 27.01%	16,890 $1.92 Million
Q2 2024 Aug 14, 2024	BUY	$123.8 - $132.96 $210,583 - $226,164	1,701 Added 7.93%	23,141 $2.86 Million
Q1 2024 May 15, 2024	BUY	$113.24 - $131.95 $2.43 Million - $2.83 Million	21,440 New	21,440 $2.83 Million
Q2 2023 Aug 14, 2023	BUY	$108.61 - $118.38 $1.05 Million - $1.14 Million	9,630 Added 280.68%	13,061 $1.51 Million
Q1 2023 May 15, 2023	BUY	$102.94 - $114.86 $353,187 - $394,084	3,431 New	3,431 $365,000
Q2 2022 Aug 15, 2022	BUY	$83.49 - $94.64 $1.04 Million - $1.18 Million	12,468 Added 475.7%	15,089 $1.38 Million
Q1 2022 May 16, 2022	BUY	$73.51 - $82.4 $192,669 - $215,970	2,621 New	2,621 $215,000
Q2 2021 Aug 16, 2021	SELL	$70.31 - $77.77 $281,240 - $311,080	-4,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $275,440 - $324,440	4,000 New	4,000 $308,000
Q3 2020 Nov 16, 2020	SELL	$73.18 - $82.95 $199,342 - $225,955	-2,724 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$70.42 - $80.13 $191,824 - $218,274	2,724 New	2,724 $211,000
Q2 2019 Aug 14, 2019	SELL	$69.84 - $81.59 $189,056 - $220,864	-2,707 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $188,353 - $214,827	2,707 New	2,707 $225,000
Q2 2018 Aug 14, 2018	SELL	$50.83 - $59.72 $1.12 Million - $1.32 Million	-22,036 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$50.96 - $59.23 $139,171 - $161,757	2,731 Added 14.15%	22,036 $1.2 Million
Q4 2017 Feb 14, 2018	BUY	$51.62 - $61.64 $996,524 - $1.19 Million	19,305 New	19,305 $1.09 Million
Q3 2017 Nov 14, 2017	SELL	$58.67 - $63.13 $528,030 - $568,170	-9,000 Closed	0 $0
Q2 2017 Aug 29, 2017	BUY	N/A	9,000	9,000 $577,000

Others Institutions Holding MRK

# of Institutions

3,827

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $248B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.

Account

Caxton Associates LP Merck & Co., Inc. Transaction History